LETTER TO THE EDITOR
A multimodal integrative approach to model transcriptional addiction of thyroid cancer on RUNX2
Emanuele Vitale, Elisabetta Sauta, Mila Gugnoni, Federica Torricelli, Veronica Manicardi, Alessia Ciarrocchi
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 4/22/2022 doi:10.1002/cac2.12292
ORIGINAL ARTICLE
HSF1 facilitates the multistep process of lymphatic metastasis in bladder cancer via a novel PRMT5-WDR5-dependent transcriptional program
Ming Huang, Wen Dong, Ruihui Xie, Jilin Wu, Qiao Su, Wuguo Li, Kai Yao, Yuelong Chen, Qianghua Zhou, Qiang Zhang, Wenwen Li, Liang Cheng, Shengmeng Peng, Siting Chen, Jian Huang, Xu Chen, Tianxin Lin
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 4/18/2022 doi:10.1002/cac2.12284
LETTER TO THE EDITOR
Intercellular communications and metabolic reprogramming as new predictive markers for immunotherapy responses in gastric cancer
Ji-Yong Sung, Jae-Ho Cheong
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 4/9/2022 doi:10.1002/cac2.12285
LETTER TO THE EDITOR
Childhood overweight and risk of obesity-related adult cancer in men
Jimmy Célind, Maria Bygdell, Jari Martikainen, Claes Ohlsson, Jenny M Kindblom
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 4/8/2022 doi:10.1002/cac2.12286
ORIGINAL ARTICLE
The five major autoimmune diseases increase the risk of cancer: epidemiological data from a large-scale cohort study in China
Ziyue Zhou, Huazhen Liu, Yiying Yang, Jingya Zhou, Lidan Zhao, Hua Chen, Yunyun Fei, Wen Zhang, Mengtao Li, Yan Zhao, Xiaofeng Zeng, Fengchun Zhang, Huaxia Yang, Xuan Zhang
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 3/31/2022 doi:10.1002/cac2.12283
LETTER TO THE EDITOR
ABTL0812 enhances antitumor effect of paclitaxel and reverts chemoresistance in triple-negative breast cancer models
Emma Polonio-Alcalá, Sònia Solé-Sánchez, Pau Mu?oz-Guardiola, Elisabet Megías-Roda, Héctor Perez-Montoyo, Marc Yeste-Velasco, Jose Alfón, Jose Miguel Lizcano, Carles Domènech, Santiago Ruiz-Martínez, Teresa Puig
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 3/16/2022 doi:10.1002/cac2.12282
ORIGINAL ARTICLE
m6A‐mediated regulation of PBX1‐GCH1 axis promotes gastric cancer proliferation and metastasis by elevating tetrahydrobiopterin levelstetrahydrobiopterin levels
Yinan Liu, Ertao Zhai, Junting Chen, Yan Qian, Risheng Zhao, Yan Ma, Jianqiu Liu, Zhixin Huang, Shirong Cai, Jianhui Chen
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 3/9/2022 doi:10.1002/cac2.12281
LETTER TO THE EDITOR
Indirect targeting of MYC sensitizes pancreatic cancer cells to mechanistic target of rapamycin (mTOR) inhibition
Christian Schneeweis, Zonera Hassan, Katja Ascherl, Matthias Wirth, Stella Koutsouli, Felix Orben, Lukas Krau?, Carolin Schneider, Rupert ?llinger, Oliver H. Kr?mer, Roland Rad, Maximilian Reichert, Maria S. Robles, Dieter Saur, Günter Schneider
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 3/7/2022 doi:10.1002/cac2.12280
LETTER TO THE EDITOR
Matrisomal genes in squamous cell carcinoma of head and neck influence tumor cell motility and response to cetuximab treatment
Kah Yee Goh, Kah Weng Lau, Terence You De Cheng, Su Chin Tham, Chwee Teck Lim, Narayanan Gopalakrishna Iyer, Su Bin Lim, Darren Wan-Teck Lim
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 3/2/2022 doi:10.1002/cac2.12279
ORIGINAL ARTICLE
The Fibrillin‐1/VEGFR2/STAT2 signaling axis promotes chemoresistance via modulating glycolysis and angiogenesis in ovarian cancer organoids and cells
Ziliang Wang, Wei Chen, Ling Zuo, Midie Xu, Yong Wu, Jiami Huang, Xu Zhang, Yongheng Li, Jing Wang, Jing Chen, Husheng Wang, Huizhen Sun
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 3/2/2022 doi:10.1002/cac2.12274
